Immuneering Corporation has established a Pancreatic Cancer Advisory Board, consisting of prominent oncology researchers, to provide strategic guidance on its lead clinical program, IMM-1-104, which ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback